Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,489 | 91 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $419.04 | 29 | $0 (2021) |
| GlaxoSmithKline, LLC. | $357.86 | 28 | $0 (2022) |
| Allergan Inc. | $147.06 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $107.98 | 8 | $0 (2021) |
| Stryker Corporation | $106.63 | 1 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $69.71 | 5 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $54.47 | 4 | $0 (2021) |
| Mylan Specialty L.P. | $48.27 | 3 | $0 (2018) |
| GENZYME CORPORATION | $44.27 | 3 | $0 (2021) |
| Circassia Pharmaceuticals Inc | $43.99 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.32 | 1 | GlaxoSmithKline, LLC. ($13.32) |
| 2021 | $162.15 | 12 | AstraZeneca Pharmaceuticals LP ($66.86) |
| 2020 | $95.58 | 7 | GlaxoSmithKline, LLC. ($41.35) |
| 2019 | $327.21 | 23 | AstraZeneca Pharmaceuticals LP ($117.60) |
| 2018 | $365.27 | 21 | Stryker Corporation ($106.63) |
| 2017 | $525.22 | 27 | Allergan Inc. ($147.06) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/28/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Respiratory | ||||||
| 10/13/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Immunology | ||||||
| 09/01/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: IMMUNOLOGY | ||||||
| 08/18/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: RESPIRATORY | ||||||
| 08/11/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: RESPIRATORY | ||||||
| 07/28/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Respiratory | ||||||
| 05/05/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Respiratory | ||||||
| 04/01/2021 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Respiratory | ||||||
| 03/31/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: IMMUNOLOGY | ||||||
| 03/18/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2021 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Respiratory | ||||||
| 12/09/2020 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2020 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Respiratory | ||||||
| 10/26/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: RESPIRATORY | ||||||
| 02/25/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: RESPIRATORY | ||||||
| 01/21/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: RESPIRATORY | ||||||
| 01/02/2020 | GlaxoSmithKline, LLC. | BREO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Respiratory | ||||||
| 12/09/2019 | GENZYME CORPORATION | DUPIXENT (Drug), DUPIXENT | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2019 | Circassia Pharmaceuticals Inc | DUAKLIR PRESSAIR (Drug), TUDORZA PRESSAIR | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 11/19/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 13 | 727 | 1,173 | $136,861 | $91,732 |
| 2020 | 14 | 878 | 2,480 | $264,292 | $180,604 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 142 | 362 | $59,265 | $39,682 | 67.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 50 | 254 | $21,755 | $16,054 | 73.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 48 | 51 | $8,550 | $6,096 | 71.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 27 | 27 | $6,850 | $5,157 | 75.3% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 84 | 84 | $7,335 | $4,724 | 64.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 32 | $5,905 | $4,497 | 76.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 59 | $6,885 | $3,859 | 56.0% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 84 | 84 | $7,970 | $3,605 | 45.2% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2021 | 83 | 83 | $5,100 | $3,370 | 66.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $3,000 | $2,053 | 68.4% |
| 94640 | Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen | Office | 2021 | 86 | 86 | $2,610 | $1,147 | 43.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 18 | 18 | $1,136 | $1,136 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 18 | $500.22 | $351.06 | 70.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 186 | 1,174 | $104,250 | $73,950 | 70.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 50 | 360 | $41,585 | $32,880 | 79.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 156 | 314 | $40,990 | $26,790 | 65.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 185 | 209 | $35,025 | $24,722 | 70.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 35 | 154 | $11,750 | $5,304 | 45.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 18 | 19 | $5,250 | $3,353 | 63.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 28 | 30 | $9,000 | $3,238 | 36.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 24 | 24 | $4,560 | $2,949 | 64.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 29 | 29 | $1,768 | $1,768 | 100.0% |
| 94729 | Measurement of lung diffusing capacity | Office | 2020 | 34 | 34 | $2,785 | $1,710 | 61.4% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 35 | 35 | $3,495 | $1,546 | 44.2% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2020 | 34 | 34 | $2,000 | $1,294 | 64.7% |
About Dr. Edward Lee, M.D
Dr. Edward Lee, M.D is a Pulmonary Disease healthcare provider based in Old Bridge, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558367821.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Lee, M.D has received a total of $1,489 in payments from pharmaceutical and medical device companies, with $13.32 received in 2022. These payments were reported across 91 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,489).
As a Medicare-enrolled provider, Lee has provided services to 1,605 Medicare beneficiaries, totaling 3,653 services with total Medicare billing of $272,336. Data is available for 2 years (2020–2021), covering 27 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Old Bridge, NJ
- Active Since 06/22/2005
- Last Updated 08/29/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558367821
Products in Payments
- SYMBICORT (Drug) $218.62
- BEVESPI AEROSPHERE (Drug) $151.12
- NATRELLE-INSPIRA (Device) $147.06
- TRELEGY ELLIPTA (Drug) $144.35
- VSP RECONSTRUCTION (Device) $106.63
- BREO (Drug) $83.43
- NUCALA (Biological) $68.76
- ACTHAR (Biological) $67.33
- BREZTRI (Drug) $37.96
- SPIRIVA RESPIMAT (Drug) $37.32
- LONHALA MAGNAIR (Drug) $36.67
- Dymista (Drug) $34.83
- ANORO (Drug) $33.36
- TUDORZA PRESSAIR (Drug) $30.43
- DUPIXENT (Drug) $29.31
- CUVITRU (Biological) $24.45
- QVAR (Drug) $23.57
- UTIBRON (Drug) $19.64
- STIOLTO (Drug) $16.87
- DUPIXENT (Biological) $14.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Old Bridge
Joseph Mathew, Md, MD
Pulmonary Disease — Payments: $3,932
Edward Mezic, Md, MD
Pulmonary Disease — Payments: $252.67
Kishore Ratkalkar, Md, MD
Pulmonary Disease — Payments: $216.78
Dr. Raj Dhakhwa, M.d, M.D
Pulmonary Disease — Payments: $32.78